Group items matching

in title, tags, annotations or url

Patients with paralysis-related speech loss could benefit from a new technology developed by University of California San Francisco (UCSF) researchers that turns brain signals for speech into written sentences.

Royal Philips has introduced the new HeartStart Intrepid monitor/defibrillator to assess and treat patients in medical emergencies across pre-hospital and hospital settings.

Seven new 'data hubs' are set to revolutionise medical research across Britain, making the medical histories of millions of NHS patients available to doctors, scientists and academics.

Research and development (R&D) in liquid biopsy is increasingly being funded by both public and private sectors due to its promising features such as early detection of cancer tumour, new lesion characterisation and identification of cancer drug target.

Liquid biopsy, a minimally invasive cancer diagnostic tool, has gained momentum in the last five years due to its advantages over the archaic painful procedure of solid tumour biopsy.

The UK government has pledged £133m to healthcare innovation funding, which will help boost the country's innovations in medical imaging and artificial intelligence (AI), among other areas.

Abbott and Sanofi are partnering to integrate their glucose sensing and insulin delivery technologies, with ambitions to simplify how people with diabetes manage their condition.

A research team led by the University of Strathclyde in the UK has developed an artificial intelligence (AI)-based blood test for the diagnosis of brain cancer.

Patients with advanced non-small cell lung cancer (NSCLC) may soon be offered a blood test to assess their treatment options, instead of having to provide a tumour sample for analysis.

Immuno-Transcriptomics firm Novigenix has received positive results from its early colon cancer detection blood test at the European Society for Medical Oncology (ESMO) 2019.

Cancer Research UK has announced a £56m research network to transform the UK into a global hub for radiotherapy study. By leveraging the use of the latest techniques, such as FLASH radiotherapy and artificial intelligence (AI), the network aims to accelerate the development of advanced radiotherapy.

Researchers from the Abramson Cancer Center of the University of Pennsylvania have found that liquid biopsy can help to predict the prognosis of glioblastoma(GBM), the most aggressive and common brain cancer in adults.

MedRhythms, a US-based digital therapeutics company, has launched its five-site randomised controlled trial (RCT) at rehabilitation hospitals and research centres to examine a post-stroke walking rehabilitation device.

The US Food and Drug Administration (FDA) has labelled a recall of circular staplers by Johnson & Johnson (J&J) unit Ethicon as Class I, or high risk.

Qiagen has launched the new therascreen PIK3CA RGQ PCR Kit as a companion diagnostic for the detection of patients who could benefit from treatment with Swiss pharmaceutical company Novartis' new breast cancer drug, Piqray (alpelisib).

Non-invasive brain stimulation may help speed up and improve vision recovery for cortically blind patients following a stroke or similar brain injury.

The US Government, industry, academia and radiology societies have worked together to publish a report that provides a blueprint for translational research on artificial intelligence (AI) in medical imaging.

Patient enrolment has begun on Biotronik's study of its new Acticor and Rivacor range of cardiac rhythm management (CRM) devices.

Read how a tissue and biological company's infrastructure and network improvements helped them save thousands of dollars in operations by implementing some core maturity models. To know more about the services visit www.mamsys.com